Cat. No. |
Product Name |
Information |
PC-49032 |
AR420626
GPR41 agonist
|
AR420626 is a potent, selective GPR41/FFA3 agonist with pEC50 of 5.74 in [35S]GTPγS-binding assays, induces apoptosis in HCC cells, including HepG2 and HLE cells. |
PC-72422 |
CFMB
FFAR2 (GPR43) agonist
|
CFMB (FFA2R agonist 58) is a potent, allosteric FFAR2 (GPR43) agonist/modulator. |
PC-72120 |
CPL207280-51
GPR40 agonist
|
CPL207280-51 is a stable, solid form of CPL207280, a potent, selective GPR40/FFA1 agonist (EC50=80 nM). |
PC-72119 |
CPL207280
GPR40 agonist
|
CPL207280 (CPL 207280) is a novel potent, selective GPR40/FFA1 agonist with EC50 of 80 nM in a Ca2+ influx assay, shows greater potency than fasiglifam (EC50=270 nM). |
PC-72109 |
SCO-267
GPR40 agonist
|
SCO-267 (SCO267) is a potent, orally available GPR40/FFAR1 full agonist with EC50 of 12 nM (hGPR40). |
PC-38228 |
MK-8666
GPR40 agonist
|
MK-8666 is a potent, selective partial GPR40 agonist with EC50 of 0.9 nM, shows potential for the treatment of type 2 diabetes mellitus. |
PC-35696 |
(S)-4CMTB
FFA2 agonist
|
(S)-4CMTB (AMG 7703, Phenylacetamide 1) is a potent, specific and allosteric agonist of FFA2 (GPR43) with cAMP IC50 of 0.7 and 0.96 uM for hFFA2 and mFFA2, respectively. |
PC-35695 |
TUG-1375
FFA2 agonist
|
TUG-1375 (TUG1375, TUG 1375) is a potent, selective free fatty acid receptor 2 (FFA2/GPR43) agonist with β-arrestin-2 pEC50 of 6.1 and cAMP pEC50 of 7.11. |
PC-35510 |
GPR40 AgoPAM AP5
GPR40 agonist
|
GPR40 AgoPAM AP5 is a potent, selective GPR40 AgoPAM (full agonist with positive allosteric modulation) with hIP1 EC50 of 0.8 nM, high selectivity over the GPR120 receptor (EC50>30 uM). |
PC-35465 |
PBI-4050 sodium
GPR40 agonist, GPR84 antagonist
|
PBI-4050 (Setogepram, Fezagepras) sodium is a synthetic analog of a medium-chain fatty acid that displays agonist and antagonist ligand affinity toward GPR40 and GPR84, respectively. |
PC-35464 |
PBI-4050
GPR40 agonist, GPR84 antagonist
|
PBI-4050 (Setogepram, Fezagepras) is a synthetic analog of a medium-chain fatty acid that displays agonist and antagonist ligand affinity toward GPR40 and GPR84, respectively. |
PC-35199 |
AM-6226
GPR40 agonist
|
AM-6226 (AM6226) is a potent, selective, orally bioavailable GPR40 (FFA1) full agonist with EC50 of 0.12 uM. |